These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24118066)

  • 1. Cyclodextrins improve oral absorption of a novel factor Xa inhibitor by interfering with interaction between the drug and bile acids in rats.
    Fujii Y; Takahashi M; Ishiguro T; Sakuma S; Uekama K; Irie T
    J Pharm Pharmacol; 2013 Nov; 65(11):1598-606. PubMed ID: 24118066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
    Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
    Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form.
    Fujii Y; Kanamaru T; Kikuchi H; Nakagami H; Yamashita S; Akashi M; Sakuma S
    Int J Pharm; 2011 Dec; 421(2):244-51. PubMed ID: 22001539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
    Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
    J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of gastrointestinal absorption of DX-9065a, a new synthetic anticoagulant.
    Fujii Y; Takahashi M; Morita H; Kikuchi H; Aramaki Y; Amidon GL
    Drug Metab Pharmacokinet; 2007 Feb; 22(1):26-32. PubMed ID: 17329908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric-coated tablets improve oral bioavailability of DX-9065, a novel anticoagulant.
    Fujii Y; Kanamaru T; Kikuchi H; Yamashita S; Sakuma S
    Eur J Pharm Sci; 2011 Mar; 42(4):392-9. PubMed ID: 21238588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration.
    Puglisi G; Ventura CA; Spadaro A; Campana G; Spampinato S
    J Pharm Pharmacol; 1995 Feb; 47(2):120-3. PubMed ID: 7602465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
    Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Taguchi K; Anraku M; Hirayama F; Uekama K; Otagiri M
    Int J Pharm; 2010 Sep; 397(1-2):1-8. PubMed ID: 20600734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
    Abe K; Irie T; Uekama K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
    Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N
    Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H; Yunomae K; Hirayama F; Uekama K
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of a new thiazolidine derivative FPFS-410, an antidiabetic and lipid-lowering drug, after oral administration of its hydroxypropyl-beta-cyclodextrin complex to bile duct-cannulated rats.
    Hara T; Arima H; Hirayama F; Uekama K
    J Pharm Sci; 2006 Aug; 95(8):1771-82. PubMed ID: 16795019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins.
    Tanino T; Ogiso T; Iwaki M; Yamaguchi T; Kakehi K
    Biol Pharm Bull; 1999 Oct; 22(10):1099-105. PubMed ID: 10549863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
    Arima H; Kondo T; Irie T; Uekama K
    J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats.
    Miyake K; Arima H; Irie T; Hirayama F; Uekama K
    Biol Pharm Bull; 1999 Jan; 22(1):66-72. PubMed ID: 9989664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of oral bioavailability of fenbufen by cyclodextrin complexations.
    Miyaji T; Inoue Y; Acartürk F; Imai T; Otagiri M; Uekama K
    Acta Pharm Nord; 1992; 4(1):17-22. PubMed ID: 1515048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution, metabolism and excretion of YM466, a novel factor Xa inhibitor, in rats.
    Mano Y; Sonoda T; Nakamura E; Usui T; Kamimura H
    Biopharm Drug Dispos; 2004 Sep; 25(6):253-60. PubMed ID: 15334624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
    Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.